A prime example is aducanumab, the medicine that many hope will cure Alzheimer’s disease.
A prime example is aducanumab, the medicine that many hope will cure Alzheimer’s disease. After a setback in March 2021, the drugmaker Biogen reported “a larger dataset for the EMERGE trial had become available, and that analysis of this dataset had shown a significant reduction in clinical decline.”